The Exon 3-Deleted Growth Hormone Receptor Is Associated with Better Response to Pegvisomant Therapy in Acromegaly

Context: The deletion of exon 3 in the GH receptor (GHR) has been associated with a different biochemical picture and response to therapy in acromegaly. Objective: The aim of the study was to determine whether or not the GHR genotype influences the efficacy of pegvisomant treatment. Design and Setti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of clinical endocrinology and metabolism 2010-01, Vol.95 (1), p.222-229
Hauptverfasser: Bernabeu, Ignacio, Alvarez-Escolá, Cristina, Quinteiro, Celsa, Lucas, Tomás, Puig-Domingo, Manel, Luque-Ramírez, Manuel, de Miguel-Novoa, Paz, Fernandez-Rodriguez, Eva, Halperin, Irene, Loidi, Lourdes, Casanueva, Felipe F, Marazuela, Mónica
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!